These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2035568)

  • 1. The relationship between autoantibodies and intrauterine growth retardation in hypertensive disorders of pregnancy.
    el-Roeiy A; Myers SA; Gleicher N
    Am J Obstet Gynecol; 1991 May; 164(5 Pt 1):1253-61. PubMed ID: 2035568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polyclonal activation of IgM antibodies to phospholipids in patients with idiopathic fetal growth retardation.
    Kajino T
    Am J Reprod Immunol; 1991 Jan; 25(1):28-34. PubMed ID: 2029330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet activation in normotensive and hypertensive pregnancies complicated by intrauterine growth retardation.
    Norris LA; Sheppard BL; Burke G; Bonnar J
    Br J Obstet Gynaecol; 1994 Mar; 101(3):209-14. PubMed ID: 8193094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prevalence of autoantibodies during third-trimester pregnancy complicated by hypertension or idiopathic fetal growth retardation.
    Milliez J; Lelong F; Bayani N; Jannet D; el Medjadji M; Latrous H; Hammami M; Paniel BJ
    Am J Obstet Gynecol; 1991 Jul; 165(1):51-6. PubMed ID: 1853915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoglobulin concentrations in newborn infants associated with intrauterine growth retardation.
    Yang SL; Lin CC; River P; Moawad AH
    Obstet Gynecol; 1983 Nov; 62(5):561-4. PubMed ID: 6621944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association of antiphospholipid antibodies with pregnancies complicated by fetal growth restriction.
    Gleicher N; Pratt D; Dudkiewicz A
    Obstet Gynecol; 1992 Apr; 79(4):637-8. PubMed ID: 1622488
    [No Abstract]   [Full Text] [Related]  

  • 7. Expression of the nonclassic histocompatibility antigen HLA-G by preeclamptic placenta.
    Colbern GT; Chiang MH; Main EK
    Am J Obstet Gynecol; 1994 May; 170(5 Pt 1):1244-50. PubMed ID: 8178845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoglobulin G and complement C3 levels in pregnancy induced hypertension.
    Ramdenee GR; Matah M; Bhatia BD; Sen MR; Swain S
    Indian Pediatr; 1995 Feb; 32(2):179-83. PubMed ID: 8635779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiphospholipid antibodies in women at risk for preeclampsia.
    Branch DW; Porter TF; Rittenhouse L; Caritis S; Sibai B; Hogg B; Lindheimer MD; Klebanoff M; MacPherson C; VanDorsten JP; Landon M; Paul R; Miodovnik M; Meis P; Thurnau G;
    Am J Obstet Gynecol; 2001 Apr; 184(5):825-32; discussion 832-4. PubMed ID: 11303189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endoglin in pregnancy complicated by fetal intrauterine growth restriction in normotensive and preeclamptic pregnant women: a comparison between preeclamptic patients with appropriate-for-gestational-age weight infants and healthy pregnant women.
    Laskowska M; Laskowska K; Oleszczuk J
    J Matern Fetal Neonatal Med; 2012 Jun; 25(6):806-11. PubMed ID: 21793708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Determination of immunoglobulins IgG, IgM and IgA in maternal serum in patients with intrauterine growth retardation].
    Möller U; Seewald HJ; Groh A; Ader B
    Zentralbl Gynakol; 1987; 109(22):1382-6. PubMed ID: 3434012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiphospholipid antibodies in pre-eclamptic women: relation to growth retardation and neonatal outcome.
    Sletnes KE; Wisløff F; Moe N; Dale PO
    Acta Obstet Gynecol Scand; 1992 Feb; 71(2):112-7. PubMed ID: 1316037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticardiolipin antibodies in pre-eclampsia and intrauterine growth retardation.
    D'Anna R; Scilipoti A; Leonardi J; Scuderi M; Jasonni VM; Leonardi R
    Clin Exp Obstet Gynecol; 1997; 24(3):135-7. PubMed ID: 9478297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoantibodies in normal and abnormal pregnancy.
    Gleicher N
    Am J Reprod Immunol; 1992; 28(3-4):269-73. PubMed ID: 1285899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do intrauterine growth restricted fetuses of the hypertensive and normotensive mothers differ from each other?
    Parlakgumus HA; Iskender C; Aytac PC; Tarim E
    Arch Gynecol Obstet; 2012 Nov; 286(5):1147-51. PubMed ID: 22791382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Serum immunoglobulin levels in newborn infants with the intrauterine dystrophy syndrome. II. Immunoglobulin levels in relation to the degree of maturity].
    Maszkiewicz W
    Pediatr Pol; 1983 Mar; 58(3):237-42. PubMed ID: 6622130
    [No Abstract]   [Full Text] [Related]  

  • 17. Angiotensin receptor agonistic autoantibodies and hypertension: preeclampsia and beyond.
    Xia Y; Kellems RE
    Circ Res; 2013 Jun; 113(1):78-87. PubMed ID: 23788505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin II type 1 receptor agonistic antibodies reflect fundamental alterations in the uteroplacental vasculature.
    Walther T; Wallukat G; Jank A; Bartel S; Schultheiss HP; Faber R; Stepan H
    Hypertension; 2005 Dec; 46(6):1275-9. PubMed ID: 16260641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrauterine growth restriction in infants of less than thirty-two weeks' gestation: associated placental pathologic features.
    Salafia CM; Minior VK; Pezzullo JC; Popek EJ; Rosenkrantz TS; Vintzileos AM
    Am J Obstet Gynecol; 1995 Oct; 173(4):1049-57. PubMed ID: 7485292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoglobulin levels in apparently normal and hypertensive Nigerian mothers at delivery.
    Ladipo OA; Williams AI; Salimonu LS
    Int J Gynaecol Obstet; 1980; 17(4):385-7. PubMed ID: 6102064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.